Bioray Biotech Co (ROCO:7561) Other Operating Expense: NT$-0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7561 Bioray Biotech Co Ltd ROCO:7561
82 GF Score
Price NT$16.90
GF Value NT$24.34
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Bioray Biotech Co Other Operating Expense?

Bioray Biotech Co ROCO:7561 -4.52% 82 Other Operating Expense is NT$-0.0 Mil as of Jun. 2026. GuruFocus rates ROCO:7561 with a GF Score™ of 82/100 and a GF Value™ of NT$24.34 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Bioray Biotech Co's Other Operating Expense for the six months ended in Jun. 2026 was NT$-0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was NT$-0.0 Mil.

Bioray Biotech Co's quarterly Other Operating Expense declined from Jun. 2025 (NT$0.0 Mil) to Dec. 2025 (NT$-0.0 Mil) but then stayed the same from Dec. 2025 (NT$-0.0 Mil) to Jun. 2026 (NT$-0.0 Mil).

Bioray Biotech Co's annual Other Operating Expense increased from Dec. 2023 (NT$-0.0 Mil) to Dec. 2024 (NT$0.0 Mil) but then stayed the same from Dec. 2024 (NT$0.0 Mil) to Dec. 2025 (NT$0.0 Mil).

Bioray Biotech Co Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Bioray Biotech Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioray Biotech Co Other Operating Expense Chart

Bioray Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -0.00 0.00 0.00

Bioray Biotech Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 -0.00 -0.00
ROCO:7561
82GF Score
Bioray Biotech Co Ltd ROCO:7561
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioray Biotech Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of NT$-0.0 Mil mean?
Bioray Biotech Co (ROCO:7561) has a Other Operating Expense of NT$-0.0 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Bioray Biotech Co and its competitors.
Is Bioray Biotech Co's Other Operating Expense too high?
Bioray Biotech Co's current Other Operating Expense is NT$-0.0 Mil. Overall, Bioray Biotech Co has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioray Biotech Co's Other Operating Expense compare to ZTS?
Bioray Biotech Co's Other Operating Expense of NT$-0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Bioray Biotech Co and its competitors. Bioray Biotech Co's current Other Operating Expense is NT$-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioray Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Bioray Biotech Co (ROCO:7561) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$24.34, compared to a current price of NT$16.90 — trading 30.6% below its estimated fair value. The current Other Operating Expense is NT$-0.0 Mil. Bioray Biotech Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Bioray Biotech Co (ROCO:7561), the current Other Operating Expense is NT$-0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioray Biotech Co (ROCO:7561) Overvalued in 2026?

Based on GuruFocus' analysis, Bioray Biotech Co stock appears to be undervalued. The current stock price of NT$16.90 is trading 30.6% below its estimated GF Value™ of NT$24.34. GuruFocus considers Bioray Biotech Co to be Significantly Undervalued.

Key valuation signals for ROCO:7561:

  • Other Operating Expense: NT$-0.0 Mil
  • GF Value™: NT$24.34 vs. price of NT$16.90 (30.6% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the ROCO:7561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioray Biotech Co Business Description

Address No. 1, Dali 2nd Road, Southern Science Park, Shanhua District, Tainan, TWN, 90846
Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations.
82GF Score

Get the complete analysis for ROCO:7561

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.90
Price
NT$24.34
GF Value